- Conditions
- Influenza, Virus Diseases
- Interventions
- H5N1 (6-2) AA ca Recombinant (A/VietNam/1203/2004 x A/AnnArbor/6/60/ca)
- Biological
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 49 Years
- Enrollment
- 42 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2007
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Showing 577–600
of 1,164
matching trials from the live ClinicalTrials.gov search.
- Conditions
- HIV, Cancer
- Interventions
- Fluzone High Dose Vaccine, Fluzone Standard Dose Vaccine
- Biological
- Lead sponsor
- St. Jude Children's Research Hospital
- Other
- Eligibility
- 3 Years to 21 Years
- Enrollment
- 85 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2013
- U.S. locations
- 1
- States / cities
- Memphis, Tennessee
- Conditions
- Immunodeficiency, Immunosuppression, HIV Infections, Graft Versus Host Disease, Leukemia, Lymphoma, Cancer, Multiple Myeloma, Transplant, Age-Related Immunodeficiency
- Interventions
- Access to Cue Health COVID-19 Remote testing and treatment for COVID-19
- Other
- Lead sponsor
- Scripps Translational Science Institute
- Other
- Eligibility
- 18 Years to 120 Years
- Enrollment
- 2,117 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- La Jolla, California
- Conditions
- Influenza
- Interventions
- GSK2340274A, GSK2340273A
- Biological
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 4,048 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2011
- U.S. locations
- 25
- States / cities
- Mesa, Arizona • Phoenix, Arizona • Los Angeles, California + 21 more
- Conditions
- H7N9 Influenza
- Interventions
- H7N9c low dose with adjuvant, H7N9c medium dose with adjuvant, H7N9c high dose with adjuvant, H7N9c high dose without adjuvant
- Biological
- Lead sponsor
- Novartis Vaccines
- Industry
- Eligibility
- 18 Years to 64 Years
- Enrollment
- 402 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2014
- U.S. locations
- 6
- States / cities
- San Diego, California • Melbourne, Florida • Peoria, Illinois + 2 more
- Conditions
- Healthy
- Interventions
- CAIV-T, CAIVT, FluMist
- Biological
- Lead sponsor
- MedImmune LLC
- Industry
- Eligibility
- 5 Years to 49 Years
- Enrollment
- 890 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2004 – 2005
- U.S. locations
- 3
- States / cities
- Shawnee Mission, Kansas • Bardstown, Kentucky • Lake Jackson, Texas
- Conditions
- Haemophilus Infections, Diphtheria, Tetanus, Polio, Pertussis
- Interventions
- DTaP-IPV/Hib
- Biological
- Lead sponsor
- Sanofi Pasteur, a Sanofi Company
- Industry
- Eligibility
- Up to 59 Months
- Enrollment
- 20,830 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2014
- U.S. locations
- 59
- States / cities
- Albany, California • Martinez, California • San Francisco, California + 56 more
- Conditions
- Influenza A H3N2, Influenza A H1N1
- Interventions
- FLU-IGIV, Placebo for FLU-IGIV
- Biological · Other
- Lead sponsor
- Emergent BioSolutions
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 65 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 42
- States / cities
- Birmingham, Alabama • Scottsdale, Arizona • Little Rock, Arkansas + 34 more
- Conditions
- Influenza, Respiratory Tract Infections
- Interventions
- Portal Reminders for Influenza Vaccination: Gain-framed, Portal Reminders for Influenza Vaccination: Loss-framed, Pre-commitment prompt
- Behavioral
- Lead sponsor
- University of California, Los Angeles
- Other
- Eligibility
- 4 Months and older
- Enrollment
- 430,636 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Influenza
- Interventions
- Peramivir
- Drug
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- Up to 17 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Ends 2012
- U.S. locations
- 29
- States / cities
- Birmingham, Alabama • Little Rock, Arkansas • Orange, California + 25 more
- Conditions
- Influenza, Human, SARS-CoV-2 Infection, COVID-19
- Interventions
- BNT162b2 (Omi XBB.1.5)/RIV, BNT162b2 (Omi XBB.1.5), RIV, Normal saline placebo
- Biological · Other
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 644 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024
- U.S. locations
- 30
- States / cities
- Lake Forest, California • Tustin, California • Walnut Creek, California + 22 more
- Conditions
- Pneumonia, Pneumococcal, Diabetes Mellitus, Breast Cancer, Colorectal Cancer
- Interventions
- Text message nudge
- Behavioral
- Lead sponsor
- Mitesh Patel
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 29,334 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
- Conditions
- COVID-19, Influenza A, Influenza Type B, RSV Infection
- Interventions
- LumiraDx SARS-CoV-2 & Flu A/B test, LumiraDx SARS-CoV-2 & RSV test
- Diagnostic Test
- Lead sponsor
- LumiraDx UK Limited
- Industry
- Eligibility
- Not listed
- Enrollment
- 589 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 8
- States / cities
- Cullman, Alabama • Encinitas, California • Miami, Florida + 5 more
- Conditions
- Healthy
- Interventions
- HAI-05 Influenza Vaccine, Saline
- Biological · Other
- Lead sponsor
- Fraunhofer, Center for Molecular Biotechnology
- Industry
- Eligibility
- 18 Years to 49 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2011
- U.S. locations
- 2
- States / cities
- Wichita, Kansas • Kansas City, Missouri
- Conditions
- Influenza
- Interventions
- Trivalent inactivated influenza vaccine
- Biological
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 39 Years · Female only
- Enrollment
- 183 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2011
- U.S. locations
- 5
- States / cities
- St Louis, Missouri • Durham, North Carolina • Nashville, Tennessee + 2 more
- Conditions
- Influenza, Virus Diseases
- Interventions
- H9N2 (6-2) AA ca Reassortant (A/Chicken/Hong Kong/G9/97 x A/Ann Arbor/6/60 ca)
- Biological
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2007
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Influenza
- Interventions
- 2008-2009 FluMist LAIV (Intranasal)
- Biological
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 24 Months to 35 Months
- Enrollment
- 6 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2009
- U.S. locations
- 1
- States / cities
- Stanford, California
- Conditions
- Influenza
- Interventions
- Influenza Virus Vaccine: Fluzone® 2012-2013 Formulation, Influenza Virus Vaccine: Fluzone® Intradermal 2012-2013 Formulation, Influenza Virus Vaccine: Fluzone® High-Dose 2012-2013 Formulation
- Biological
- Lead sponsor
- Sanofi Pasteur, a Sanofi Company
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 200 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2013
- U.S. locations
- 4
- States / cities
- Boca Raton, Florida • South Miami, Florida • Council Bluffs, Iowa + 1 more
- Conditions
- Decision-Making, Patient Care, Treatment Decisions
- Interventions
- Influenza vaccine, Placebo
- Biological · Other
- Lead sponsor
- University of Arkansas, Fayetteville
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 210 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2027
- U.S. locations
- 3
- States / cities
- Fayetteville, Arkansas • Albuquerque, New Mexico • Roanoke, Virginia
- Conditions
- Influenza, Vaccination
- Interventions
- Messaging, Incentive
- Behavioral
- Lead sponsor
- The University of Texas Health Science Center at Tyler
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 22,584 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Austin, Texas
- Conditions
- Influenza Vaccine
- Interventions
- TIV, Trivalent Inactivated Influenza Virus Vaccine, FluMist, Influenza Virus Vaccine Live
- Biological
- Lead sponsor
- MedImmune LLC
- Industry
- Eligibility
- 12 Months to 35 Months
- Enrollment
- 101 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007 – 2008
- U.S. locations
- 19
- States / cities
- Jonesboro, Arkansas • Little Rock, Arkansas • Anaheim, California + 16 more
- Conditions
- Fever
- Interventions
- Not listed
- Lead sponsor
- Columbia University
- Other
- Eligibility
- 6 Months to 23 Months
- Enrollment
- 530 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 2
- States / cities
- Atlanta, Georgia • New York, New York
- Conditions
- Central Nervous System Neoplasm
- Interventions
- trivalent influenza vaccine, laboratory biomarker analysis
- Biological · Other
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 38 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 1
- States / cities
- Winston-Salem, North Carolina
- Conditions
- Pregnancy
- Interventions
- influenza and general health information, general health information
- Other
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- 14 Years to 50 Years · Female only
- Enrollment
- 216 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2014
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania